Emergent BioSolutions
Supplies naloxone sprays and government-procured medical countermeasures for public-health emergencies.
$5.82
After-hours close−0.09 (−1.61%)
At close$5.92(−0.42%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 88.76%45.79M sharesInsiders 5.97%3.08M sharesOther 5.27%2.72M shares
Shares outstanding 51.60M · Float 48.72M · 94.4% free float
Institutions13F, as of Jun 30, 2026
201 holders · 45.79M shares · 34 new positions · 105 increased · 62 reduced · 27 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 4.72M | 9.14% | +375.1K | Aug 7, 2026 |
| Dimensional Fund Advisors LP | 3.08M | 5.96% | +319.5K | Aug 11, 2026 |
| State Street Corp | 2.93M | 5.68% | +79.5K | Aug 7, 2026 |
| American Century Companies Inc | 2.77M | 5.37% | +344.7K | Aug 12, 2026 |
| Vanguard Capital Management LLC | 2.20M | 4.26% | −59.2K | Aug 13, 2026 |
| LSV Asset Management | 1.70M | 3.29% | +799.2K | Aug 6, 2026 |
| Acadian Asset Management LLC | 1.34M | 2.61% | −37.3K | Aug 13, 2026 |
| Geode Capital Management, LLC | 1.34M | 2.59% | +64.3K | Aug 12, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 7.30% | 3.98M | 13G | Jul 17, 2025 ↗ |
| Oak Hill Advisors, L.P. | 6.39% | 3.61M | 13G | Nov 13, 2024 ↗ |
| American Century Investment Management, Inc.incl. American Century ETF Trust, Stowers Institute for Medical Research +1 more | 5.40% | 2.77M | 13G | Aug 14, 2026 ↗ |
| Dimensional Fund Advisors LP | 5.30% | 2.76M | 13G | Apr 9, 2026 ↗ |
| State Street Corporation | 5.10% | 2.70M | 13G | Feb 9, 2026 ↗ |
| Vanguard Capital Management | 5.04% | 2.61M | 13G | Apr 29, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Joseph C. Papa | director, officer: President and CEO | 493.2K | 0.96% | May 1, 2026 |
| Richard S. Lindahl | officer: EVP, Chief Financial Officer | 374.1K | 0.73% | Jun 10, 2026 |
| Coleen Glessner | officer: EVP, Quality & Ethics, and CPL | 202.2K | 0.39% | Jun 10, 2026 |
| Stephanie Duatschek | officer: EVP, CGO | 197.4K | 0.38% | Aug 12, 2026 |
| William Hartzel | officer: SVP, Bioservices | 185.6K | 0.36% | Jun 10, 2026 |
| Simon C. Lowry | officer: SVP, R&D, CMO | 177.9K | 0.34% | May 1, 2026 |
| Jessica Perl | officer: SVP, General Counsel, Corp Sec | 165.3K | 0.32% | May 1, 2026 |
| Neal Franklin Fowler | director | 160.8K | 0.31% | May 4, 2026 |
| Paul Anthony Williams | officer: SVP, Products Business | 159.1K | 0.31% | Jul 2, 2026 |
| Zsolt Harsanyi | director, officer: Chairman | 149.1K | 0.29% | May 4, 2026 |
5 ten-percent owners hold 11.21M shares by Form 4, outside the officers-and-directors figure above · 24 people have not refiled in the last 18 months (2.26M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jul 1, 2026 | Paul Anthony Williamsofficer: SVP, Products Business | Sale | 3,000 | $8.40 | 159,098 |
| May 1, 2026 | Kathryn C. Zoondirector | Sale · 2 lots | 17,202 | $8.40 | 79,941 |
| Apr 30, 2026 | Keith Katkindirector | Sale | 15,481 | $8.28 | 96,294 |
| May 1, 2026 | Donald W. DeGolyerdirector | Sale · 2 lots | 15,481 | $8.40 | 129,721 |
| May 1, 2026 | Sujata Tyagi Dayaldirector | Sale · 2 lots | 13,761 | $8.40 | 100,563 |
| Apr 1, 2026 | Paul Anthony Williamsofficer: SVP, Products Business | Sale | 4,000 | $8.44 | 62,681 |
| Dec 5, 2025 | Ronald Richarddirector | Sale · 2 lots | 21,984 | $11.97 | 98,417 |
| Nov 10, 2025 | Donald W. DeGolyerdirector | Sale | 17,801 | $10.54 | 119,858 |
| Nov 7, 2025 | Sujata Tyagi Dayaldirector | Sale | 8,552 | $10.00 | 88,980 |
| Oct 7, 2025 | Coleen Glessnerofficer: EVP, Quality & Ethics, and CPL | Sale | 30,608 | $10.00 | 144,319 |
CongressHouse and Senate disclosures
Not reported.